Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated?...

33
Decontamination : Who, why, when and how

Transcript of Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated?...

Page 1: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Decontamination : Who, why, when and how

Page 2: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Decontamination

When should patient be decontaminated?

risk of morbidity and/or mortality associated with ingestion

What type of decontamination should be used?

Depends on clinical circumstances and other treatment options

Page 3: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Decontamination

Syrup of Ipecac Gastric lavage Activated charcoal

• multi dose• with cathartic

Whole bowel irrigation

Page 4: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Where is the Evidence ?Based on Animal studies Volunteer studies clinical studies

Difficulty due to serious ingestions excluded conflicting results

Page 5: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Where is the EvidencePosition statements released in 1997 by

AACT and EAPCCT

“Overall the mortality from acute poisoning is less than 1 % and the challenge for clinicians is to identify promptly those who are at most risk of developing serious complications and who might potentially benefit, therefore, from gastrointestinal decontamination.”

Page 6: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Syrup of Ipecac

Plant extract previously abused by bullimics needs to be given EARLY induces vomiting by gastric and central mechanism

Contraindicated in unprotected airway corrosive very little evidence for or against possible role in the home for children

Page 7: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Gastric lavage

No studies demonstate efficacy even < 60 min.s

Studies exclude serious poisonings

Contraindicated: dodgy airway reflexes corrosives hydrocarbon

Page 8: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Gastric lavage May increase risk of aspiration May lead to pharyngeal injury alleged to increase absorption in some cases Has lead to significant return of ingestants up to 12

hours post ingestion(salicylates)

Indication Serious life threatening poisoning with well

protected airway

(level IV evidence)

Page 9: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Activated charcoal Will adsorb many toxins in GI tract BUT:

• Alcohols• Li+, Fe 2+ (probably all alkali metals)

Ratio should be 10:1 AC:toxin Evidence from volunteer studies that absorption will

be if < 60 min.s Little to suggest benefits outcome clinically or

absorption post 60 min.s

DO NOT GIVE ROUTINELY

Page 10: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Activated charcoal

Beware the unprotected airway or aspiration risk dose is 50g adult, 1g/kg in a child

Cathartics Alleged to increase bowel transit time of toxin Evidence only from animal and volunteer studies Unlikely to benefit

Page 11: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Multi dose activated charcoal

Works by• GI dialysis• drugs with significant enterohepatic circulation

examples:• theophylline• anticonvulsants• salicylates • digoxin

Page 12: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Multi dose activated charcoal

Good, though indirect evidence of effect in digoxin poisoning

50g q 6 hrly OR by NG infusion if intubated

up to 1g/kg suggested for serious theophylline poisonings

Justifies “late” instigation of charcoal

Page 13: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Whole bowel irrigation

Used for SR/EC preparations when charcoal is ineffective No controlled clinical studies to back up use

physically speeds up transit through GI tract

single dose charcoal given prior to starting

Page 14: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Whole bowel irrigation PEG ELS (“go-lytely”) is used does not cause

significant water/electrolyte disturbance frequently causes vomiting, requires NGT airway must be protected ileus is CI but has been reversed with neostigmine dose is 15-20 mls/kg/hr endpoint is clear rectal effluent, median time to

achieve this is 6 hours

Page 15: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

A 50 kg female presents having ingested 6 g of paracetamol 5 hours previously

Page 16: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Would You

Syrup of Ipecac Gastric lavage Gastric Lavage & AC Gastric lavage & Whole bowel lavage AC Whole Bowel Lavage None

Page 17: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

A 70 kg male presents having ingested 14 g paracetamol 3 hours before

Page 18: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Would You

Syrup of Ipecac Gastric lavage Gastric Lavage & AC Gastric lavage & Whole bowel lavage AC Whole Bowel Lavage None

Page 19: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

A 70 kg male presents having ingested 14 g paracetamol 1 hour before

Page 20: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Would You

Syrup of Ipecac Gastric lavage Gastric Lavage & AC Gastric lavage & Whole bowel lavage AC Whole Bowel Lavage None

Page 21: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

A 45 kg female presents having ingested 2 g of a tricyclic antidepressant 1 hour before

Page 22: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Would You Syrup of Ipecac Gastric lavage Gastric Lavage & AC Gastric lavage & Whole bowel lavage AC Whole Bowel Lavage None

Page 23: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

A 50 kg male presents unconscious having ingested an unknown amount of a tricyclic antidepressant at an unknown time

Page 24: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Would You Syrup of Ipecac Gastric lavage Gastric Lavage & AC Gastric lavage & Whole bowel lavage AC Whole Bowel Lavage None

Page 25: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

A 67 kg male presents having ingested 800 mg of a tricyclic antidepressant 6 hours before. He is well.

Page 26: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Would You Syrup of Ipecac Gastric lavage Gastric Lavage & AC Gastric lavage & Whole bowel lavage AC Whole Bowel Lavage None

Page 27: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

A 80 kg male presents having ingested 100 mg of diazepam 4 hours before

Page 28: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Would You

Syrup of Ipecac Gastric lavage Gastric Lavage & AC Gastric lavage & Whole bowel lavage AC Whole Bowel Lavage None

Page 29: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Would You

Syrup of Ipecac Gastric lavage Gastric Lavage & AC Gastric lavage & Whole bowel lavage AC Whole Bowel Lavage None

Page 30: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

A 65 kg female presents having ingested 3.5 g of Verapamil SR 4 hours before.

Page 31: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Would You Syrup of Ipecac Gastric lavage Gastric Lavage & AC Gastric lavage & Whole bowel lavage AC Whole Bowel Lavage None

Page 32: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

A 45 kg female presents having ingested 2 g elemental iron 4 hours before. Tablets are noted on her plain AXR

Page 33: Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Would You Syrup of Ipecac Gastric lavage Gastric Lavage & AC Gastric lavage & Whole bowel lavage AC Whole Bowel Lavage None